Mice infected with Brucella abortus 19 were challenged intravenously with Listeria monocytogenes. Spleen assays to determine the number of viable Listeria cells present revealed that these mice were highly resistant to Listeria when challenged on day 17 of the Brucella infection. Resistance was absent in mice challenged on the 5th day and was declining in mice challenged on the 33rd day. Resistance could not be detected by day 49 of the Brucella infection but could be recalled by the injection of antigens from smooth B. abortus 2308. Thus, extracted antigens appeared to be as effective in recall as the live cells used in earlier studies. Similar injections of extracts from rough B. abortus 45/20, or from B. ovis REO 198, were also effective in recalling resistance; this suggests that the smooth surface agglutinogen may be relatively unimportant in recall.
Resistance to diseases caused by facultative intracellular parasites is believed to be mediated primarily by cellular, rather than humoral, mechanisms (7, 17) . Cellular immunity or acquired cellular resistance appears to be the result of an immunologically specific reaction which is nonspecific in its antimicrobial effects (15) . The establishment of resistance endows the host with macrophages which are effective, for a time, against organisms which are antigenically (4-6, 13), taxonomically (2, 3, 15, 24) , or even phylogenetically (20) (21) (22) (23) unrelated to the original infecting parasite.
The duration and degree of immunity appear to be influenced by the persistence of antigen (3-6, 14-16, 20, 23) . In mice, resistance to challenge with Listeria monocytogenes begins to decline as the previously established Brucella infection enters the latent phase but can be recalled by the injection of live Brucella (15) . Although Mackaness and Blanden (17) (10, 25) .
Suspensions of L. monocytogenes used for inoculation were prepared and handled in the same manner; BHI agar and broth were used as the growth media, and the slants were incubated for 24 to 36 hr.
Spleen assays. The number of viable bacteria per milliliter of spleen homogenate from mice was determined by the method of Mackaness (14) . In assays for Brucella, spleens were homogenized in 5.0 ml of brucella broth, and appropriate decimal dilutions were plated in duplicate on well dried brucella agar plates. Colonies were counted and checked for smoothness after 4 to 5 days of incubation at 37 C. BHI broth and agar were used in the assays for Listeria. Colonies were counted after 24 to 36 hr of incubation.
Antigens. The water extracts of sonically disrupted B. abortus 2308, strain 45/20, and B. ovis REO 198 were prepared by using the method of Hinsdill and Berman (11) . The staphylococcal antigen, mostly cell walls and debris, was obtained by disrupting Staphylococcus aureus in a Ribi Cell Fractionator. The method for growing, harvesting, and breaking the cells was described by Gagliano and Hinsdill (9) . The suspension of broken cells was centrifuged at 7,000 X g for 45 min. The pellet was suspended in distilled water and freeze-dried. All antigens were suspended in HBSS-V for injection into mice.
Recall experiments. For any one experiment, the general procedure was as follows. A (Fig. 1, bottom) .
T (11) water extract of sonically disrupted B. abortus 2308 which has been shown to act in skin tests and tissue culture studies much the same as whole killed cells (12) . Each mouse received a total of 1 mg (dry weight) as described above.
The growth curves of the Listeria in each of the five groups (see above) are shown in Fig. 2 One hundred mice were inoculated with 1.3 X (Fig. 3) indicate that a sonic extract of the rough, avirulent B. abortus 45/20 is effective in recalling cellular immunity. A sonic extract from B. ovis, another rough Brucella, somewhat more distant taxonomically from strain 19, has been tested in similar experiments with the same results.
Specificity of recall. To insure that there was some antigenic specificity to the recall phenomenon, cell walls and debris obtained from disrupted S. aureus were used as an antigen. One hundred mice were inoculated with 9.8 x 105 B. abortus 19. Half of the mice were injected with 1.0 mg of the staphylococcal antigen on day 52 of the Brucella infection. On day 57, all of the mice were challenged with L. monocytogenes. The 100 normal control mice were assayed in the same manner 6 days later. The results (Fig. 4) show that this antigen did not recall a state of nonspecific resistance.
DISCUSSION
The growth pattern (Fig. 1) of B. abortus 19 in normal mouse spleens is similar to that reported by Mackaness (15) . The infection may be separated into three distinct phases: a period of multiplication, a period of bacterial inactivation, and a period of latency. Enhanced resistance to the heterologous organism L. monocytogenes is observed only when mice are challenged during the period of bacterial inactivation (middle Listeria curves, Fig. 1 ). Brucella-infected mice show no resistance to Listeria when the heterologous challenge is given during the period of Brucella multiplication (Fig. 1, left- hand Listeria curves). Nonspecific resistance begins to decline early in the latent phase (Fig. 1, right- hand Listeria curves) and disappears by day 49 of the Brucella infection (Fig. 2-4, group III) .
The rapid decay of antibacterial immunity shown here for a Brucella infection is typical of diseases caused by facultative intracellular parasites. Other workers have demonstrated a similar decay in mice infected with Listeria (14) or Salmonella (5) . The development of a critical antigenic mass seems to be an essential step in the establishment of cellular immunity (16, 17) . As the level of antigen declines, the level of immunity also declines. However, a sudden increment in antigenic material to which the host is sensitized can recall the nonspecific phase of immunity. In previous studies, recall has been elicited by the injection of live homologous organisms (2, 5, 17) . The resistance to Listeria challenge in group IV mice shown in Fig. 2-3 indicates that extracted antigens are as effective as live cells in recalling immunity. Collins (5) found that the rate of recall in salmonellosis was related to the persistence of antigen. As the number of residual vaccinating microorganisms declined, the rate of recall also declined. A similar observation was made with Brucella in this study. Early in the latent phase of infection, approximately 105 viable bacteria per ml of spleen homogenate could be recovered from the spleens of Brucella-infected mice (Fig.  1) . By day 90 of infection, the number of residual bacteria had dropped to less than 102 per ml of spleen homogenate. Brucella-infected mice injected with antigen on day 44 were highly resistant to Listeria challenge 5 days later (Fig.  2, group IV) . Mice injected with antigen on day 93 (Fig. 2 , group V) also developed resistance to the heterologous challenge, but at a reduced rate.
Virulence in Brucella is normally associated with smooth strains. The injection of antigen from B. abortus 45/20, a rough avirulent strain, was an indirect test to determine the importance of the smooth-surface antigen, believed to be the agglutinogen, in the recall of immunity. The extract from strain 45/20 (Fig. 3, group IV) was as effective as the extract from strain 2308 (Fig. 2 (18) found that an intraperitoneal injection of 104 B. melitensis Rev I was incapable of recalling immunity, as measured by in vitro challenge of macrophages, in guinea pigs which had been vaccinated earlier with strain Rev I. That these animals had been primed to some degree, however, was evident from the fact that these animals did exhibit recall when injected with a more virulent strain.
